Table S1: OddsPath calculations for MAVE data validated on control variants.,,,,,,,,,,,,,,,,
Gene,Assay,Control set,Total Controls,Pathogenic Controls,Benign Controls,Prior Probability Pathogenic,Total Assay Abnormal,Total Assay Normal,True Path in Abnormal,True Path in Normal,Proportion Path in Abnormal,Proportion Path in Normal,Odds Pathogenic Functionally Abnormal,Odds Pathogenic Functionally Normal,Functionally Abnormal Code,Functionally Normal Code
BRCA1,HAP1 saturation genome editing,ClinGen Expert Panel,67,48,19,0.7164,48,19,47,1,0.9792,0.0526,18.6,0.0220,PS3_strong,BS3_strong
BRCA1,HAP1 saturation genome editing,ClinVar,375,209,166,0.5573,201,163,198,4,0.9851,0.0245,52.4,0.0200,PS3_strong,BS3_strong
TP53,NB-classifier predictions,ClinVar,162,130,32,0.8025,123,39,123,7,0.9919,0.1795,30.3,0.0538,PS3_strong,BS3_moderate
TP53,Etoposide LOF screen,ClinVar,162,130,32,0.8025,120,51,118,19,0.9752,0.3725,9.7,0.1462,PS3_moderate,BS3_moderate
TP53,Nutlin-3 LOF screen,ClinVar,162,130,32,0.8025,110,78,109,46,0.982,0.5897,13.4,0.3538,PS3_moderate,BS3_supporting
PTEN,VAMPseq (abundance),ClinVar,97,95,2,0.9796,58,31,58,29,0.9831,0.9355,1.2,0.3021,Indeterminate,BS3_supporting
PTEN,PTEN phosphatase activity,ClinVar,126,124,2,0.9841,73,26,73,24,0.9865,0.9231,1.2,0.1935,Indeterminate,BS3_moderate